HLA typing associated with hepatitis B E antigen seroconversion in children with chronic hepatitis B virus infection: A long-term prospective sibling cohort study in Taiwan

Journal of Pediatrics

Volumn 148, Issue 5, 2006, Pages

  Wu, Jia Feng ^a,b,c   Chen, Chen Hsin ^a,b,c   Hsieh, Rhong Phong ^a,b,c   Shih, Hsiang Hung ^a,b,c   Chen, Yi Hau ^a,b,c   Li, Chi Rong ^a,b,c   Chiang, Chih Yao ^a,b,c   Shau, Wen Yi ^a,b,c   Ni, Yen Hsuan ^a,b,c   Chen, Huey Ling ^a,b,c   Hsu, Hong Yuan ^a,b,c   Chang, Mei Hwei ^a,b,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B ANTIGEN; HLA DQB1 ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC HEPATITIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FOLLOW UP; HEPATITIS B; HLA TYPING; HUMAN; INFANT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; SIBLING; TAIWAN;

EID: 33646833969     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2005.12.025     Document Type: Article

References (35)

1. Beasley R.P., Hwang L.Y., Lin C.C., and Chien C.S. Hepatocellular carcinoma and hepatitis B virus. a prospective study of 22,707 men in Taiwan. Lancet 2 (1981) 1129-1133
2. Liu Z., Luo K., He H., and Hou J. Hot-spot mutations in hepatitis B virus core gene. eliciting or evading immune clearance?. J Viral Hepat 12 (2005) 146-153
3. Nordenfelt E., and Andren-Sandberg M. Dane particle-associated DNA polymerase and e antigen. relation to chronic hepatitis among carriers of hepatitis B surface antigen. J Infect Dis 134 (1976) 85-89
4. Fattovich G., Rugge M., Brollo L., Pontisso P., Noventa F., Guido M., et al. Clinical, virologic, and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology 6 (1986) 167-172
5. Yang H.I., Lu S.N., Liaw Y.F., You S.L., Sun C.A., Wang L.Y., et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347 (2002) 168-174
6. Su I.J., Lai M.Y., Hsu H.C., Chen D.S., Yang P.M., Chuang S.M., et al. Diverse virological, histological and prognostic implications of seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. J Hepatol 3 (1986) 182-189
7. Beasley R.P., Trepo C., Stevens C.E., and Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 105 (1977) 94-98
8. Hsu S.C., Chang M.H., Ni Y.H., Hsu H.Y., and Lee C.Y. Horizontal transmission of hepatitis B virus in children. J Pediatr Gastroenterol Nutr 16 (1993) 66-69
9. Hsu H.Y., Chang M.H., Chen D.S., Lee C.Y., and Sung J.L. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984. a study just before a mass hepatitis B vaccination program in Taiwan. J Med Virol 18 (1986) 301-307
10. Chang M.H., Sung J.L., Lee C.Y., Chen C.J., Chen J.S., Hsu H.Y., et al. Factors affecting clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children. J Pediatr 115 (1989) 385-390
11. Hsu H.Y., Chang M.H., Hsieh K.H., Lee C.Y., Lin H.H., Hwang L.H., et al. Cellular immune response to HBcAg in mother-to-infant transmission of hepatitis B virus. Hepatology 15 (1992) 770-776
12. Rosenberg W. Mechanisms of immune escape in viral hepatitis. Gut 44 (1999) 759-764
13. Bertoni R., Sidney J., Fowler P., Chesnut R.W., Chisari F.V., and Sette A. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J Clin Invest 100 (1997) 503-513
14. Terasaki P.I., and McClelland J.D. Microdroplet assay of human serum cytotoxins. Nature 204 (1964) 998-1000
15. Olerup O., and Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. an alternative serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantations. Tissue Antigens 39 (1992) 225-235
16. Olerup O., Aldener A., and Fogdell A. HLA-DQB1 and DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 41 (1993) 119-134
17. Klein J.P. Semiparametric estimation of random effects using the Cox model based on the EM algorithm. Biometrics 48 (1992) 795-806
18. Klein J.P., and Moeschberger M.L. Survival analysis. techniques for censored and truncated data. 2nd ed. (2003), Springer-Verlag, New York
19. Turnbull B.W. The empirical distribution function with arbitrarily grouped, censored and truncated data. J Royal Statist Soc B 38 (1976) 290-295
20. Frydman H. A note on nonparametric estimation of the distribution function from interval-censored and truncated observations. J Royal Statist Soc B 56 (1994) 71-74
21. Shen S.W., Hu C.Y., Lin C.Y., Yang Y.C., and Hsieh R.P. Human leukocyte antigen polymorphisms in the Taiwanese population. J Formos Med Assoc 98 (1999) 11-18
22. Shaw C.K., Chen L.L., Lee A., and Lee T.D. Distribution of HLA gene and haplotype frequencies in Taiwan. a comparative study among Min-nan, Hakka, Aborigines and Mainland Chinese. Tissue Antigens 53 (1999) 51-64
23. Zavaglia C., Bortolon C., Ferrioli G., Rho J., Mondazzi L., Bottelli R., et al. HLA typing in chronic type B, D and C hepatitis. J Hepatol 24 (1996) 658-665
24. Thursz M.R., Kwiatkowski D., Allsopp C.E., Greenwood B.M., Thomas H.C., and Hill A.V. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 332 (1995) 1065-1069
25. Hohler T., Gerken G., Notghi A., Lubjuhn R., Taheri H., Protzer U., et al. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J Hepatol 26 (1997) 503-507
26. Ahn S.H., Han K.H., Park J.Y., Lee C.K., Kang S.W., Chon C.Y., et al. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 31 (2000) 1371-1373
27. Yang P.M., Sung J.L., and Chen D.S. HLA-A, B, C, and DR antigens in chronic hepatitis B virus infection. Hepatogastroenterology 36 (1989) 363-366
28. Almarri A., and Batchlor J.R. HLA and hepatitis B infection. Lancet 344 (1994) 1994-1995
29. Wu Y.F., Wang L.Y., Lee T.D., Lin H.H., Hu C.T., Cheng M.L., et al. HLA phenotypes and outcomes of hepatitis B virus infection in Taiwan. J Med Virol 72 (2004) 17-25
30. Wong D.K., Dudley D.D., Afdhal N.H., Dienstag J., Rice C.M., Wang L., et al. Liver-derived CTL in hepatitis C virus infection. breadth and specificity of responses in a cohort of persons with chronic infection. J Immunol 160 (1998) 1479-1488
31. Rehermann B., Lau D., Hoofnagle J.H., and Chisari F.V. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest 97 (1996) 1655-1665
32. Sobao Y., Tomiyama H., Sugi K., Tokunaga M., Ueno T., Saito S., et al. The role of hepatitis B virus-specific memory CD8 T cells in the control of viral replication. J Hepatol 36 (2002) 105-115
33. Higashi Y., Kamikawaji N., Suko H., and Ando M. Analysis of HLA alleles in Japanese patients with cirrhosis due to chronic hepatitis C. J Gastroenterol Hepatol 11 (1996) 241-246
34. Tsai S.L., Chen P.J., Lai M.Y., Yang P.M., Sung J.L., Huang J.H., et al. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. J Clin Invest 89 (1992) 87-96
35. Godkin A., Davenport M., and Hill A.V. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology 41 (2005) 1383-1390